UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
September
02, 2026
Commission
File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s
name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F ✔
Form 40-F
__
SMITH & NEPHEW PLC
2 September 2026
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse
Regulation (Regulation (EU) 596/2014, as it forms part of domestic
law by virtue of the European Union (Withdrawal) Act
2018).
1. PERFORMANCE SHARE AWARD MADE UNDER THE PERFORMANCE
SHARE PLAN 2026
On 1 September 2026, the following award of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") has been
granted to Nate Folkert under the Smith & Nephew Performance
Share Plan 2026. The award has been calculated using a market price
of £11.0265, being the average of the quoted closing prices of
a Share for the ten (10) dealing days immediately following the
announcement of the Company's First Half results on 4 August
2026.
The award will vest on 15 March 2029 subject to the achievement of
performance conditions measured over the period 1 January 2026 to
31 December 2028.
The number of shares subject to the above award are shown at
maximum vesting. Should less than maximum vesting be achieved, Nate
Folkert will receive a reduced number of shares in accordance with
actual performance. Nate Folkert will receive an additional number
of shares equivalent to the amount of dividend payable per vested
share during the relevant performance period.
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Performance Share award granted under the Smith
& Nephew Performance Share Plan 2026.
|
|
Date of Transaction
|
2026 - 09 - 01
|
|
Place of Transaction
|
Grant took place outside a trading venue
|
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Nate Folkert
(President, Orthopaedics)
|
PDMR
|
11.0265
|
117,933
|
N/A Single Transaction
|
2. AWARD
MADE UNDER THE RESTRICTED SHARE PLAN 2024
On 1 September 2026, the following award of US$0.20 ordinary shares
(the "Shares") in Smith & Nephew plc (the "Company") were
granted to Nate Folkert under the Smith & Nephew Restricted
Share Plan 2024. The award has been calculated using a market price
of £11.0265, being the average of the quoted closing prices of
a Share for the ten (10) dealing days immediately following the
announcement of the Company's First Half results on 4 August
2026.
The award will vest in equal annual tranches over three years
following the award date. Each vesting is subject to Nate Folkert
remaining in the employment of the Group on the vesting dates, not
being under notice and not having achieved an "unsatisfactory
performance" rating for his personal performance in the year prior
to each vesting date.
Nate Folkert will receive an additional number of shares equivalent
to the amount of dividend payable per vested share during the
relevant vesting period.
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Restricted Share award granted under the Smith & Nephew
Restricted Share Plan 2024
|
|
Date of Transaction
|
2026 - 09 - 01
|
|
Place of Transaction
|
Grant took place outside a trading venue
|
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Nate Folkert
(President, Orthopaedics)
|
PDMR
|
11.0265
|
67,164
|
N/A Single Transaction
|
Helen Barraclough
Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
September 02, 2026
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|
